Blueprint Medicines Corporation carries a market capitalization of 6.28B, placing it among publicly traded companies globally.
| Market Cap | 6.28B |
| Enterprise Value | N/A |
Blueprint Medicines Corporation's stock has gained approximately 36.16226% over the past 52 weeks. The 50-day moving average sits at 85.09, while the 200-day moving average is 68.07.
| Beta (5Y) | N/A |
| 52-Week Price Change | 36.16226% |
| 50-Day Moving Average | 85.09 |
| 200-Day Moving Average | 68.07 |
| Average Volume (20 Days) | N/A |